Canterbury DHB

Context

Non-Hodgkin Lymphoma

In This Section

Introduction

Classification

Lymphoma MDT

Laboratory Diagnosis

Staging

Prognosis, Risk Factors, and the Decision to Treat

Pre-Treatment Investigations for Aggressive NHL

Current Trials in NHL

Management of Non-Trial Patients

Stem Cell Grafts in NHL and Hodgkin Lymphoma

About this Canterbury DHB document (5966):

Document Owner:

Peter Ganly (see Who's Who)

Issue Date:

November 2018

Next Review:

November 2021

Keywords:

Note: Only the electronic version is controlled. Once printed, this is no longer a controlled document. Disclaimer

Topic Code: 5966